Mark Worthington Athira Pharma, Inc. (ATHA) insider trading activity

Mark Worthington is General Counsel and CCO of Athira Pharma, Inc.. Currently has a direct ownership of 51,927 shares of ATHA, which is worth approximately $30,117. The most recent transaction as insider was on Sep 05, 2024, when has been sold 2,525 shares (Common Stock) at a price of $0.57 per share, resulting in proceeds of $1,439. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.9K

0% 3M change

93.3% 12M change

Total Value Held $30,117

Mark Worthington Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 05 2024	SELL Open market or private sale	$1,439 $0.57 p/Share	2,525 Reduced 4.64%	51,927 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	-	10,000 Added 15.52%	54,452 Common Stock
May 20 2024	BUY Grant, award, or other acquisition	$13,400 $1.34 p/Share	10,000 Added 18.36%	44,452 Common Stock
Jan 05 2024	SELL Open market or private sale	$7,018 $2.91 p/Share	2,412 Reduced 6.54%	34,452 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	10,000 Added 21.34%	36,864 Common Stock
May 18 2023	BUY Grant, award, or other acquisition	$18,718 $2.41 p/Share	7,767 Added 22.43%	26,864 Common Stock
Jun 23 2022	SELL Open market or private sale	$7,032 $2.69 p/Share	2,614 Reduced 12.04%	19,097 Common Stock
Jun 22 2022	BUY Grant, award, or other acquisition	-	10,000 Added 31.53%	21,711 Common Stock
May 18 2022	BUY Grant, award, or other acquisition	$23,976 $7.06 p/Share	3,396 Added 22.48%	11,711 Common Stock

Mark Worthington

General Counsel and CCO

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Value

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Athira Pharma, Inc.

Track Activities on ATHA

Account